Prediction of tumor progression in intermediate and advanced hepatocellular carcinoma undergoing TACE combined with targeted immunotherapy [0.03%]
预测经导管动脉化疗栓塞联合靶向免疫治疗中晚期肝细胞癌患者肿瘤进展的风险
Lina Sun,Yanqiu Li,Qiang Zhao et al.
Lina Sun et al.
Background: Transcatheter arterial chemoembolization (TACE) combined with targeted immunotherapy have become the standard first-line treatment strategy for intermediate and advanced hepatocellular carcinoma (HCC), but som...
Transformation of a gluteal type 1 plexiform neurofibroma into a high-grade malignant peripheral nerve sheath tumor: a rare case report [0.03%]
臀部1型plexiform神经纤维瘤转化为高度恶性外周神经鞘肿瘤的罕见病例报告
Hui Huang,Yang Xiao,Wei Li et al.
Hui Huang et al.
Neurofibromatosis type 1 is a rare autosomal dominant disorder with heterogeneous clinical manifestations. Under certain conditions, plexiform neurofibromas may undergo malignant transformation into the more aggressive malignant peripheral ...
Advances in neurotensin receptor 1-targeted molecular probes for tumor molecular imaging and therapy [0.03%]
神经紧张素受体1分子探针研究进展：肿瘤分子影像与治疗中的应用挑战及机遇
Chengkuan Liu,Jiang Fu,Shengjie Tang et al.
Chengkuan Liu et al.
Neurotensin receptor 1 (NTS1) is a high-affinity G protein-coupled receptor (GPCR) for the endogenous peptide neurotensin (NT). NTS1 is overexpressed across multiple malignancies and is an important target for precision theranostics. In rec...
Correction: A mammalian, glutaminase-free asparaginase enhances venetoclax activity in preclinical AML models with chromosome 7 deletion [0.03%]
纠正：一种无谷氨酰胺酶的小鼠哺乳动物天冬酰胺酶可增强Venetoclax在染色体7缺失的白血病细胞系和异种移植模型中的活性
Dhabya Majid,Zhe Wang,Amanda M Schalk et al.
Dhabya Majid et al.
[This corrects the article DOI: 10.3389/fonc.2025.1606239.]. Keywords: AML; AML with deletion 7; acute myeli...
Published Erratum
Frontiers in oncology. 2026 Apr 23:16:1824040. DOI:10.3389/fonc.2026.1824040 2026
Savolitinib in brain and leptomeningeal metastases from non-small cell lung cancer: a case report [0.03%]
萨沃利替尼治疗非小细胞肺癌脑膜转移1例报告
Xuejiao Qi,Zhijiao Song,Junying He et al.
Xuejiao Qi et al.
In the population with non-small cell lung cancer (NSCLC), the incidence of mesenchymal-epithelial transition factor exon 14 (METex14) skipping mutations is approximately 3%-4%. However, the prevalence of this mutation appears to be lower a...
Stereotactic radiotherapy for brain metastases: indications, dose fractionation, technological innovations, and evolving combination strategies - a comprehensive review [0.03%]
立体定向放射治疗脑转移瘤：指征、分割剂量、技术革新和组合策略的演变——全面综述
Hu Chen,Shuai Li,Qiuyu Yang et al.
Hu Chen et al.
The incidence of brain metastases in cancer patients is increasing due to improved survival from systemic therapies and advancements in diagnostic imaging. Radiotherapy remains a cornerstone in the management of brain metastases. Among the ...
Correction: Range quality assurance measurements for clinical and FLASH proton beam therapy using the quality assurance range calorimeter [0.03%]
订正：临床和FLASH质子治疗的范围质量保证测量使用质量保证范围 calorimeter
Saad Shaikh,Sonia Escribano-Rodriguez,Raffaella Radogna et al.
Saad Shaikh et al.
[This corrects the article DOI: 10.3389/fonc.2025.1622231.]. Keywords: FLASH; photodiode; plastic scintillat...
Published Erratum
Frontiers in oncology. 2026 Apr 24:16:1824636. DOI:10.3389/fonc.2026.1824636 2026
Adult and pediatric cystic nephroma: an easily misdiagnosed renal tumor [0.03%]
成人和儿科囊性肾瘤：一种容易误诊的肾脏肿瘤
Guo Run Zi,Da-Jiang Zhang,Dong-Lin He et al.
Guo Run Zi et al.
Background: Cystic nephroma (CN) is a rare, benign renal tumor often misdiagnosed due to overlapping radiological features with simple renal cysts and malignant cystic neoplasms. CN primarily affects boys and adult female...
Immunoconjugates in cervical cancer: a bibliometric and thematic mapping analysis of global research trends, 2015-2024 [0.03%]
宫颈癌免疫偶联物的文献计量和主题映射分析（2015-2024年全球研究趋势）
Xiaodong Wang,Di Xiong,Songli Cui et al.
Xiaodong Wang et al.
Background: Immunoconjugates, particularly antibody drug conjugates, are emerging as clinically relevant options for recurrent or metastatic cervical cancer. A quantitative overview of how this field has evolved over the ...
Interval-compressed chemotherapy in patients with Ewing's sarcoma: report on feasibility and toxicity from a North African center [0.03%]
EWING肉瘤患者接受间期压缩化疗的可行性和毒性分析：北非某中心报告
Nesrine Kooli,Hajer Ben Mansour,Yosr Zenzri et al.
Nesrine Kooli et al.
Background: Ewing's sarcoma (ES) is the second most common malignant bone tumor in patients under 20 years of age. The "Euro-Ewing 2012" trial established induction therapy with the 2-week-interval VDC/IE (Vincristine-Dox...